Stay Vigilant When Prescribing Fentanyl
March 2021
You’ll see more focus on safe use of transdermal and transmucosal fentanyl products.
Issues continue to crop up with fentanyl patches.
Plus there are now updated Risk Evaluation and Mitigation Strategies (REMS) requirements for transmucosal immediate-release fentanyl (TIRF) products (Actiq, Fentora, etc)...partly to ensure they’re only used in opioid-tolerant patients.
Get concise advice on drug therapy, plus unlimited access to CE
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.
Already a subscriber? Log in
Volume pricing available. Get a quote